4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000170
Chief Executive Officer sold 2,432 shares at $45.00 ($109,440)
- Chief Executive Officer acquired 2,432 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Monia Brett P · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,432 | $32.60 | $79,283 | 182,252 | D |
| 2025-07-30 | Sale : show line 2 in the form 10b5-1 | −2,432 | $45.00 | $109,440 | 179,820 | D |
| Open-market sales · 2,432 sh · avg $45.00 · $109,440 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-30 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −2,432 | 99,057 | D |
Loading xslF345X05/edgardoc.xml…